WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Stereo Investigator
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harik, S. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harik, S. I.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 4, 699-707, Copyright © 1984 by Society for Neuroscience


ARTICLE

Locus ceruleus lesion by local 6-hydroxydopamine infusion causes marked and specific destruction of noradrenergic neurons, long-term depletion of norepinephrine and the enzymes that synthesize it, and enhanced dopaminergic mechanisms in the ipsilateral cerebral cortex

SI Harik

The local stereotaxic microinfusion of 5 micrograms of 6- hydroxydopamine in the region of the nucleus locus ceruleus causes severe loss of noradrenergic neurons with little evidence of nonspecific tissue reaction or destruction that could be detected by conventional light microscopic methods. Such lesion is accompanied by a marked and long-term depletion of norepinephrine and comparable loss of activity of its synthesizing enzymes, dopamine beta-hydroxylase and tyrosine hydroxylase, in the ipsilateral cerebral cortex. Locus ceruleus lesion was also found to increase tissue levels of dopamine and its metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, in the ipsilateral cortex. These results add further evidence to support the hypothesis that enhanced dopaminergic mechanisms may play a central role in compensating for chronic cortical noradrenergic denervation.


This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. W. Berridge and S. L. Foote
Enhancement of Behavioral and Electroencephalographic Indices of Waking following Stimulation of Noradrenergic beta -Receptors within the Medial Septal Region of the Basal Forebrain
J. Neurosci., November 1, 1996; 16(21): 6999 - 7009.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-